Hamid  Vaez

Dr. Hamid Vaez


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 December 2012 in Critical Care Research and Practice
Verified
Journal Article
Open access
PDF file
HGHamed Ghadiri
Hamed Ghadiri
HVHamid Vaez
Hamid Vaez
SKSamira Khosravi
Samira Khosravi
ESEbrahim Soleymani
Ebrahim Soleymani
Treatment of nosocomial infections is becoming difficult due to the increasing trend of antibiotics resistance. Current knowledge on antibiotic resistance pattern is essential for appropriate therapy. We aimed to evaluate antibiotic resistance profiles in nosocomial bloodstream and urinary tract pathogens. A total of 129 blood stream and 300 urinary tract positive samples were obtained from patients referring to Besat hospital over a two-year period (2009 and 2010). Antibiotic sensitivity was ascertained using the Kirby-Bauer disk diffusion technique according to CLSI guidelines. Patient's data such as gender and age were recorded. The ratio of gram-negative to gram-positive bacteria in BSIs was 1.6 : 1. The most prevalent BSI pathogen was Coagulase-NegativeStaphylococci(CoNS). The highest resistance rate of CoNS was against penicillin (91.1%) followed by ampicillin (75.6%), and the lowest rate was against vancomycin (4.4%).Escherichia coliwas the most prevalent pathogen isolated from urinary tract infections (UTIs). Ratio of gram-negative to gram-positive bacteria was 3.2 : 1. The highest resistance rate ofE. coliisolates was against nalidixic acid (57.7%). The present study showed that CoNS andE. coliare the most common causative agents of nosocomial BSIs and UTIs, and control of infection needs to be addressed in both antibiotic prescription and general hygiene.

31 August 2010 in International Journal of Microbiology
Verified
Journal Article
Open access
PDF file
FSFatemeh Shakeri
Fatemeh Shakeri
ASAbolfath Shojai
Abolfath Shojai
MGMasoud Golalipour
Masoud Golalipour
SASomaye Rahimi Alang
Somaye Rahimi Alang
HVHamid Vaez
Hamid Vaez
EGEzzat Allah Ghaemi
Ezzat Allah Ghaemi
Protein A ofStaphylococcus aureusis a pathogenic factor whose encoding gene,spa, shows a variation in length in different strains. In this study thespagene variation inS. aureusisolated from healthy carriers and patients was studied, We also compared this variation among MRSA with MSSA strains. 208 strains ofStaphylococcus aureuswhich we were isolated from Gorgan, north of Iran were studied, 121 cases from patients and 87 cases from healthy carriers, 59 out of them wereMRSAand 149MSSA. Samples DNA were extracted and amplified by specific primer ofspagene. In 4 (3.8%) strains of them nospagene was detected, and 10.6% had a dual band (1200 and 1400 bp). In strains with one band, the length ofspagene differed from 1150 to 1500 bp. The most prevalent length was 1350–1400 bp (37%). The frequencies of shortspabands (1150–1200 bp) in patients strains were significantly higher. In 4 (3.8%) strains of them nospagene was detected, and 10.6% had a dual band (1200 and 1400 bp). In strains with one band, the length ofspagene differed from 1150 to 1500 bp. The most prevalent length was 1350–1400 bp (37%). The frequencies of shortspabands (1150–1200 bp) in patients strains were significantly higher. Thespagene length of 1350–1400 bp in MSSA was more than in MRSA strains (P<.05). The average length ofspain isolated strains from urinary tract infections was more than others. It is concluded that the length ofspagene depends either on resistance to Methicillin or the source ofS. aureusisolation.

1 September 2017 in Journal of Global Antimicrobial Resistance
Verified
Journal Article
Closed access
FKFarzad Khademi
Farzad Khademi
ASAmir Hossein Sahebkar
Amir Hossein Sahebkar
HVHamid Vaez
Hamid Vaez
MAMohsen Arzanlou
Mohsen Arzanlou
HPHadi Peeridogaheh
Hadi Peeridogaheh

1 September 2018 in Microbial Drug Resistance
Verified
Journal Article
Closed access
AAarshid yousefi avarvand
arshid yousefi avarvand
HVHamid Vaez
Hamid Vaez
MTMohsen Tafaghodi
Mohsen Tafaghodi
ASAmir Hossein Sahebkar
Amir Hossein Sahebkar
MAMohsen Arzanlou
Mohsen Arzanlou
FKFarzad Khademi
Farzad Khademi
Antibiotic therapy for children infected with Helicobacter pylori is important. However, resistance to antibiotics is one of the main causes of treatment failure. This study was designed to evaluate the prevalence pattern of antibiotic resistance of H. pylori in Iranian children using a systematic review and meta-analysis of literature. A computerized search (until June 10, 2017) using related keywords in the national and international databases was performed. A total of 261 original articles on antibiotic resistance of H. pylori in Iranian children were collected. After screening for inclusion and exclusion criteria, six eligible articles were included in the meta-analysis. Resistance rates of H. pylori to different antibiotics were as follows: metronidazole: 71%, clarithromycin: 12.2%, amoxicillin: 20.4%, tetracycline: 8.4%, ampicillin: 21.4%, rifampin: 28.6%, furazolidone: 8.4%, ciprofloxacin: 16.2%, azithromycin: 19%, erythromycin: 15.3%, and nitrofurantoin: 0%. The prevalence of H. pylori resistance to metronidazole, amoxicillin, ampicillin, and rifampin among Iranian children was high. Therefore, a careful monitoring of antibiotic resistance to select the best treatment options and prevent treatment failure is required. Although resistance to some antibiotics such as clarithromycin, tetracycline, furazolidone, and ciprofloxacin was less prevalent, frequent consumption of these drugs in children should be controlled owing to their known adverse events.

1 September 2018 in Folia Medica
Verified
Journal Article
Open access
PDF file
FKFarzad Khademi
Farzad Khademi
AAarshid yousefi avarvand
arshid yousefi avarvand
ASAmirhossein Sahebkar
Amirhossein Sahebkar
FGFahimeh Ghanbari
Fahimeh Ghanbari
HVHamid Vaez
Hamid Vaez
Background: Bacterial infections are the most common complications in people with HIV/AIDS. There has been no previous report on the prevalence of bacterial co-infections in Iranian HIV/AIDS-positive subjects. Aim: To evaluate the frequency of bacterial infections in hospitalized HIV/AIDS-infected patients in Iran. Materials and methods: Based on PRISMA guidelines, a computerized search in related data banks using relevant keywords was performed in both Persian and English languages for articles that were published until March 10, 2017. A total of 1118 original articles were systematically reviewed to identify eligible studies on the prevalence of bacterial co-infections in HIV/AIDS-infected patients from Iran. After screening for inclusion and exclusion criteria, we extracted data from 28 eligible articles for the meta-analysis. Results: The overall bacterial infection rate among Iranian HIV/AIDS-positive individuals was estimated to be 48.6%. Gastrointestinal disorders (59.5%) were the most frequent bacterial infections in this group of patients followed by bacterial lymphadenopathy (38.9%), TB infection (38.2%), bacterial pneumonia (31.2%), brucellosis (26.3%), skin infections (13.3%) and sexually transmitted infections (9.7%). The prevalence of other bacterial infections including endocarditis, sepsis and Staphylococcus aureus (S. aureus) were 10%, 9.1%, and 6.9%, respectively. Conclusion: The prevalence of a wide spectrum of bacterial co-infections, especially endemic infections, in Iranian HIV/AIDS-infected patients, is alarming and calls for urgent need to improve the currently applied diagnostic and preventive methods. In addition, timely treatment of these infections is pivotal to decrease the morbidity and mortality rates in HIV/AIDS-infected patients.

1 January 2014 in Advanced Biomedical Research
Verified
Journal Article
Open access
PDF file
HSHajieh Ghasemian Safaei
Hajieh Ghasemian Safaei
HVHamid Vaez
Hamid Vaez
JFJamshid Faghri
Jamshid Faghri
BIBahram Nasr Isfahani
Bahram Nasr Isfahani
SMSharareh Moghim
Sharareh Moghim
MMMohsen Moghofeei
Mohsen Moghofeei
Background: Multidrug resistance Pseudomonas aeruginosa (MDR-P. aeruginosa) is a worldwide threat for public health. Hyperexpression of efflux pump systems (MexAB-OprM and MexCD-OprJ), which is a well-known mechanisms for MDR emerging, is controlled by regulatory genes, mexR and nfxB, respectively. The aim of this study was to evaluate point mutations in mexR and nfxB genes in MDR- P. aeruginosa isolated from wound infections. Materials and Methods: A total of 34 P. aeruginosa cultures obtained from wound infections were analyzed. Among them eight isolates identified as MDR-P. aeruginosa and were subjected to determination of mutations in mexR and nfxB genes. Results: We detected eight-point mutations in mexR and 12-point mutations in nfxB. The most common mutations were common G327-A (eight isolates), G384-A (eight isolates), G411-A (eight isolates). Mutations in A371-C and A372-C were the predominant substitution which was seen in nfxB. Amino acid substitutions were also found at position 124 and 126 for NfxB and MexR, respectively. Conclusions: P. aeruginosa isolates with mutation in efflux pump regulatory genes such as mexR and nfxB could be a main factor contributed to antibiotic resistance and must be considered in antibiotic treatment.